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RELATIONSHIP BETWEEN QUALITY OF LIFE
AND COGNITIVE STATUS AMONG LONG-TERM
CARE FACILITY RESIDENTS IN WEST VIRGINIA:
A PILOT STUDY
Johnson JK1, Scott VG1, Mody RR1,Atkinson WL2
1West Virginia University, Morgantown, WV, USA; 2Aegis
Health, Lewisburg, WV, USA
OBJECTIVE: The Omnibus Reconciliation Act of 1987
(OBRA ‘87) requires trained clinical professionals in
nursing homes to complete an assessment called the
Minimum Data Set (MDS) to evaluate the functional,
medical, psychosocial, and cognitive status for each 
resident. The objective of this pilot study is to examine
the relationship between cognitive status as measured by
the MDS Cognitive Performance Scale (CPS) and quality-
of-life as measured by the Quality-of-Life in Late-Stage
Dementia (QUALID) scale among residents of West 
Virginia (WV) long-term care (LTC) facilities.
METHODS: A cross-sectional study was completed using
a convenience sample of 339 residents from 10 LTC facil-
ities in WV. CPS scores for residents were calculated by
a consultant pharmacist from the MDS scores. Direct care
assistants assessed residents’ quality-of-life using the
QUALID scale, which evaluates 11 observational 
behaviors on a 5-point scale with scores ranging from 11
(best) to 55 (worst). Descriptive statistics and one-way
ANOVAs were conducted to examine differences in
quality-of-life among residents with intact cognitive func-
tion (CPS = 0), mild cognitive impairment (CI) (CPS =
1,2), moderate CI (CPS = 3,4) and severe CI (CPS = 5,6).
RESULTS: The mean age for residents was 78.5 years.
QUALID and CPS mean scores were 24.07 and 3.34,
respectively. Mean QUALID scores for individuals with
severe CI (27.1 ± 7.8) were signiﬁcantly higher (p < 0.00)
than for individuals with intact cognitive function (20.0
± 7.3), mild CI (21.4 ± 7.8) and moderate CI (22.9 ± 9.2).
One-way ANOVAs showed no differences for QUALID
and CPS scores based on age categories and gender. CON-
CLUSIONS: Results of this study show that cognitive
status, as indicated by CPS scores, signiﬁcantly affects
QUALID scores. Based on QUALID scores, LTC residents
with more severe CI have signiﬁcantly lower quality-of-
life. Further studies are needed to determine if improved
changes in QUALID scores postpone decline of cognitive
status or if interventions which delay deteriorating 
cognitive status improve quality-of-life.
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OBJECTIVES: To evaluate the average per-patient cost of
Alzheimer’s disease (AD) versus vascular dementia from
the perspective of the Medicaid program. METHODS:
Using administrative claims data for Medicaid recipients
in the Southeastern U.S., we assessed Medicaid expendi-
tures among adults 50+ years of age diagnosed with vas-
cular dementia (ICD-9-CM 290.4) or AD (ICD-9-CM
331.0) during FY2001. Patients with either condition
who were eligible for Medicaid at the beginning of the
year were included in the study. Multivariate techniques
were employed to estimate adjusted mean expenditures
while controlling for sociodemographic differences
between the study cohorts. RESULTS: In total, 2310
patients met study inclusion criteria; 490 were diagnosed
with vascular dementia and 1820 with AD. Relative to
AD patients, those diagnosed with vascular dementia
were younger (mean age 77 vs. 81 years for AD patients),
more likely to be male (32% vs. 24%), and more likely
to be African American (22% vs. 15%). The burden 
of comorbidity was higher among vascular dementia
patients, especially for cerebrovascular disease (25% vs.
9%), but also for congestive heart failure (9% vs. 5%)
and diabetes mellitus (14% vs. 6%). Mean Medicaid
expenditures were approximately $6,300 higher for
patients with vascular dementia versus AD ($31,390 vs.
$25,102; p < 0.0001). Nursing home facility stays (56%)
and hospitalizations (29%) contributed to most of this
excess cost. Adjusting for differences in age, gender, 
and race between the two cohorts, average per-patient
expenditures were about $5320 higher in the vascular
dementia group. CONCLUSIONS: We found that rela-
tive to patients with AD, Medicaid recipients diagnosed
with vascular dementia have signiﬁcantly higher health-
care costs. The increased expenditures for vascular
dementia reﬂect in part the higher prevalence of associ-
ated cardiovascular conditions, and correspondingly, a
greater use of institutional services. Efforts to better
control cardiovascular risk factors may help alleviate the
future burden of vascular dementia.
AG4
INAPPROPRIATE DRUG PRESCRIBING IN
OUTPATIENT CARE FOR THE ELDERLY:THE
CASE OF POTENTIALLY HARMFUL DRUG-DRUG
AND DRUG-DISEASE COMBINATIONS
Zhan C1, Correa-de-Araujo R1,Wickizer S2, Miller MR3,
Bierman A1
1AHRQ, Rockville, MD, USA; 2NCI, Frederick, MD, USA; 3Johns
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OBJECTIVES: Inappropriate prescribing is a major
patient safety concern in the aged population. Prescribing
of individual agents inappropriate for the elderly regard-
less of diagnosis or concomitant medications has been
studied extensively. However, little is known about the
prevalence and circumstances of potentially harmful
drug-disease and drug-drug combinations in this popula-
